Your Cart ( 1 Item )

• Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis
  July 2018 | Volume 17 | Issue 7 | Original Article | 750 | Copyright © July 2018
  Marita Zimmermann MPH PhD,^a David Rind MD MS^c,b Rick Chapman PhD, MS,^b Varun Kumar MBBS MPH MS^c,b Sonya Kahn MPH,^b Josh Carlson PhD MPH^a
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs